2379 studies found for:    Open Studies | "Endocrine System Diseases"
Show Display Options
Rank Status Study
21 Unknown  Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Conditions: Type 2 Diabetes Mellitus;   Insulin Resistance
Intervention: Drug: Resveratrol
22 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
23 Recruiting Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: NBI-77860
24 Recruiting A Study of the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
Condition: Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Metformin
25 Recruiting Oral Testosterone for the Treatment of Hypogonadism in Males
Condition: Hypogonadism
Intervention: Drug: TSX-002
26 Recruiting Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Other: AMNIOEXCEL;   Other: Standard of Care, Diabetic Foot Ulcers
27 Unknown  Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
28 Recruiting Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment
Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: human pancreatic islet transplantation
29 Recruiting A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Device: PaQ® Insulin Delivery Device
30 Recruiting A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: HM11260C;   Drug: Placebo;   Drug: Victoza
31 Recruiting RTA 402 Phase 2 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients With Chronic Kidney Disease and Type 2 Diabetes)
Conditions: Chronic Kidney Disease;   Type 2 Diabetes
Interventions: Drug: RTA 402;   Drug: Placebo
32 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
33 Recruiting Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Blood Glucose
Interventions: Device: Guardian Enlite sensor;   Device: Dexcom G4 platinum sensor
34 Recruiting Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin 5 mg;   Drug: Placebo 5 mg for Saxagliptin;   Drug: Placebo 500 mg for metformin (with titration);   Drug: Metformin 500 mg with titration
35 Recruiting Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin 5mg;   Drug: Placebo for Saxagliptin
36 Recruiting Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
37 Recruiting A Trial to Compare the Safety of Once Weekly Dosing of NNC0195-0092 With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
Conditions: Adult Growth Hormone Deficiency;   Growth Hormone Disorder
Interventions: Drug: NNC0195-0092;   Drug: somatropin
38 Recruiting Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: NNC0195-0092;   Drug: somatropin;   Drug: placebo
39 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
40 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years